TCS whitepaper

Reimagining the Clinical Trials Process through Digital Disruption

Conventional clinical trial processes require significant time and resources to be invested for data cleaning, monitoring, and reporting to the concerned regulatory authorities. This directly influences the cost of the trial, and thus the time to market. Explore how digitization of clinical trial processes can help transform the clinical research industry. The clinical trials industry manages large volumes of patient data …

Model N whitepaper

Five Critical Success Factors to Achieve Global Pricing Excellence in Life Sciences

2015 Annual Survey – Global Pricing in Life Sciences By Model N and High Point Solutions “The $US300 billion pharmaceuticals industry is undergoing a profound transformation. Cost containment initiatives by payers, governments and healthcare insurance organizations have created a challenging business environment with controlled pricing, promotion of generic alternatives and greater obstacles to bringing innovative drugs to market. With changing dynamics in the industry, achieving …

Elsevier whitepaper

Meeting pharmacovigilance and medical device post-market surveillance requirements

Elsevier R&D Solutions for Pharma and Life Science: extracts from Elsevier’s whitepaper  THE FUNDAMENTALS OF MONITORING LITERATURE Monitoring literature for product citations would be an impossible task if not for modern research informatics solutions. Corporate, academic and government pharmaceutical and medical research facilities produce in excess of 20 terabytes of data per day. Even with only a fraction of this data …

Download Whitepaper: Functionality of silicone oil-free syringe system

Download whitepaper: Functional Evaluation and Characterization of a Newly Developed Silicone Oil-Free Prefillable Syringe System Paper Abstract:  The functionality of a newly developed silicone oil-free (SOF) syringe system, of which the plunger stopper is coated by a novel coating technology (i-coating™), was assessed. By scanning electron microscopy observations and other analysis, it was confirmed that the plunger stopper surface was uniformly …

Ebook: Your essential guide on trends, regulations and new technologies in Drug Safety

Drug safety must continue to evolve to meet heightened patient expectations and the fluctuating regulatory climate. It is becoming critical to exploit opportunities offered by emerging technologies, big data and personalised healthcare. To succeed in this new environment, we need to assess the regulatory updates; we need to examine how to implement regulations strategically and operationally in addition to discussing …

Slava Epstein - iCHIP

Uncharted territory: iCHIP’s potential to generate high-throughput antibiotic production

Earlier this year, a promising antibiotic named teixobactin with the ability to vanquish drug-resistant pathogen was discovered. Early results show teixobactin to be active against the deadly bacterium MRSA (methicillin-resistant Staphylococcus aureus) in mice. This important discovery was made possible by the work Slava Epstein and his lab, who developed the iCHIP technology. Story originally posted by Nature. Follow this link to view the original …

Brian Bachman, featured on VICE

Life in a Post-Antibiotic Era – Vice News

Like many, we here at Terrapinn are big fans of HBO’s Vice News. They cover many topics – and they cover them well. A few weeks back they had a segment on Anti-microbial resistance titled “The Post-Antibiotic Era”. Within it, they featured a few scientists in the space working on unique research. One of them was Brian Bachmann, a researcher …

The History of Antibiotics

Antimicrobial resistance is one of the most important subjects of the 21st century. With the potential to cause nearly $100 trillion in damage to the world health and economy, the issue of infections untreatable by modern antibiotics is one that leaves many concerned and looking for answers. What’s even more concerning is the scarce, almost empty antibiotic pipeline. Between 1935 and …

Embracing big data and emerging technologies in drug safety

Which new approaches are pharma companies taking to exploit opportunities offered by big data? We’ll be answering this question and many more as we discuss big data and related innovative technologies at World Drug Safety Congress Europe. Hear from a plethora of thought leaders who will be sharing real life examples of how to develop big data programmes and social media …

Press Release: MyMeds&Me announce collaboration with Oracle Health Sciences

Oracle Argus Safety customers gain access to the Reportum® solution to further streamline and strengthen their Pharmacovigilance operations London, UK, 25 March, 2015: MyMeds&Me, a leading SaaS provider of web-based adverse event and product quality capture solutions for life sciences, today announced their collaboration with Oracle Health Sciences to provide the Reportum® solution to Oracle Argus safety customers. This collaboration …